Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.

Insull, W; Black, D; Dujovne, C; Hosking, J D; Hunninghake, D; Keilson, L; Knopp, R; McKenney, J; Stein, E; Troendle, A J

Insull, W; Black, D; Dujovne, C; Hosking, J D; Hunninghake, D; Keilson, L; Knopp, R; McKenney, J; Stein, E; Troendle, A J.

Affiliation

Insull W; Lipid Research Clinic, Baylor College of Medicine, Methodist Hospital, Houston.

Arch Intern Med ; 154(21): 2449-55, 1994 Nov 14.

Article in En | MEDLINE | ID: mdl-7979841

Subject(s)

Fatty Acids, Monounsaturated/therapeutic use; Hypercholesterolemia/drug therapy; Indoles/therapeutic use; Adult; Aged; Apolipoproteins E/genetics; Double-Blind Method; Fatty Acids, Monounsaturated/administration & dosage; Fatty Acids, Monounsaturated/adverse effects; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia/blood; Hypercholesterolemia/genetics; Indoles/administration & dosage; Indoles/adverse effects; Lipids/blood; Male; Middle Aged; Phenotype

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Fatty Acids, Monounsaturated / Hypercholesterolemia / Indoles Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arch Intern Med Year: 1994 Type: Article

Search on Google

XML

PubMed Links